← SynDRA
TOPIROXOSTAT
SynDRA canonical compound SYN0021312 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Primary target(s) | XDH |
| Mechanism of action | Xanthine oxidase inhibitor |
| Indication | gout | hyperuricemia |
| Disease area | nephrology | rheumatology |
All known targets
Mechanisms of action (all sources)
- Xanthine oxidase inhibitor
- XDH INHIBITOR
- Xanthine dehydrogenase inhibitor
Drug classes
Cross-references
Synonyms
- SK-0910
- topiloric
- uriadec
- FYX-051
- Xanthine oxidoreductase inhibitor (oral, gout), Fuji Yakuhin
- FYX 051
- 0J877412JV
- topiroxostatum
- RefChem:898615
- DTXCID80128953
- Topiroxostat [INN]
- MFCD17167057
- 4-(5-(pyridin-4-yl)-1H-1,2,4-triazol-3-yl)picolinonitrile
- 4-(3-(Pyridin-4-yl)-1H-1,2,4-triazol-5-yl)picolinonitrile
- 5-(2-cyano-4-pyridyl)-3-(4-pyridyl)-1,2,4-triazole
- UNII-0J877412JV
- Uriadec (TN)
- Topiroxostat (Standard)
- Topiroxostat (JAN/INN)
- TOPIROXOSTAT [MI]
- TOPIROXOSTAT [JAN]
- Topiroxostat(FYX-051)?
- SCHEMBL860420
- TOPIROXOSTAT [WHO-DD]
- orb1305544
- SCHEMBL4680577
- SCHEMBL18056618
- SCHEMBL29403929
- GTPL10592
- C13H8N6
- UBVZQGOVTLIHLH-UHFFFAOYSA-N
- GLXC-06067
- HMS5082G03
- EX-A1197
- BDBM50267750
- BDBM50311275
- HY-14874R
- MSK160033
Look up TOPIROXOSTAT in the interactive SynDRA portal →